Summit Trail Advisors »

Xilio Therapeutics shares owned by Summit Trail Advisors

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Summit Trail Advisors from 13F filings

Historical chart of Summit Trail Advisors investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Summit Trail Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Summit Trail Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $17k 16k 1.08

More positions owned by Summit Trail Advisors

Wisdomtree Tr Floatng Rat Trea (USFR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Ishares Tr Core Us Aggbd Et (AGG)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Broadcom (AVGO)
Invesco Exchange Traded Fd T Aerospace Defn (PPA)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Apple (AAPL)
Expeditors International of Washington (EXPD)
Kraneshares Trust California Carb (KCCA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Summit Trail Advisors

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
FMR
RiverVest Venture Management
Rock Springs Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Balyasny Asset Management
Morgan Stanley
Fil
Geode Capital Management
Bridgeway Capital Management
Millennium Management
BlackRock
SevenBridge Financial
PFG Investments

View all funds holding Xilio Therapeutics